73 related articles for article (PubMed ID: 7789929)
1. [Anti-HIV drugs work rapidly or not at all. Virus dynamics--therapeutic consequences].
Aulehla S
Fortschr Med; 1995 Apr; 113(12):14-6. PubMed ID: 7789929
[No Abstract] [Full Text] [Related]
2. Ongoing HIV dissemination during HAART.
Grossman Z; Polis M; Feinberg MB; Grossman Z; Levi I; Jankelevich S; Yarchoan R; Boon J; de Wolf F; Lange JM; Goudsmit J; Dimitrov DS; Paul WE
Nat Med; 1999 Oct; 5(10):1099-104. PubMed ID: 10502799
[No Abstract] [Full Text] [Related]
3. Eradication timetable setback.
TreatmentUpdate; 1999 May; 11(3):3-4. PubMed ID: 11366780
[TBL] [Abstract][Full Text] [Related]
4. [New biological monitoring of HIV infection].
Morand-Joubert L
Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
[No Abstract] [Full Text] [Related]
5. Can HIV be eradicated?
Pantaleo G; Perrin L
AIDS; 1998; 12 Suppl A():S175-80. PubMed ID: 9633000
[No Abstract] [Full Text] [Related]
6. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
Marcello A; Giacca M
Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
[No Abstract] [Full Text] [Related]
7. HIV-1 dynamics in vivo.
Ho DD
J Biol Regul Homeost Agents; 1995; 9(3):76-7. PubMed ID: 8782010
[No Abstract] [Full Text] [Related]
8. HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management.
Phillips AN; McLean A; Johnson MA; Tyrer M; Emery V; Griffiths P; Bofill M; Janossy G; Loveday C
J Med Virol; 1997 Nov; 53(3):261-5. PubMed ID: 9365893
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
Sankatsing SU; van Praag RM; van Rij RP; Rientsma R; Jurriaans S; Lange JM; Prins JM; Schuitemaker H
Antivir Ther; 2003 Apr; 8(2):137-42. PubMed ID: 12741626
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
[TBL] [Abstract][Full Text] [Related]
11. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
12. Mutation and control of the human immunodeficiency virus.
Stengel RF
Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
[TBL] [Abstract][Full Text] [Related]
13. [Can HIV/AIDS be healed with new therapies?].
Battegay M
Praxis (Bern 1994); 1997 May; 86(22):931-2. PubMed ID: 9289789
[No Abstract] [Full Text] [Related]
14. HIV-1 and HAART: a time to cure, a time to kill.
Saag MS; Kilby JM
Nat Med; 1999 Jun; 5(6):609-11. PubMed ID: 10371490
[No Abstract] [Full Text] [Related]
15. [Prognostic indices for the course of HIV infection].
Hess G
Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
[No Abstract] [Full Text] [Related]
16. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
Ho DD; Neumann AU; Perelson AS; Chen W; Leonard JM; Markowitz M
Nature; 1995 Jan; 373(6510):123-6. PubMed ID: 7816094
[TBL] [Abstract][Full Text] [Related]
17. HIV chemotherapy.
Richman DD
Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.
Chun TW; Engel D; Mizell SB; Hallahan CW; Fischette M; Park S; Davey RT; Dybul M; Kovacs JA; Metcalf JA; Mican JM; Berrey MM; Corey L; Lane HC; Fauci AS
Nat Med; 1999 Jun; 5(6):651-5. PubMed ID: 10371503
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
Moriuchi H; Moriuchi M
Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
[TBL] [Abstract][Full Text] [Related]
20. [Campaign against a chameleon. Therapeutic strategies to control a survival artist].
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():80-1. PubMed ID: 10863320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
